Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Corboy

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Pediatric Neurology|November 1, 2006
Neuromyelitis optica immunoglobulin G in a childLynsee A Hudson, Timothy J Bernard, Brian S Tseng, et al.
Clinical Breast Cancer|October 28, 2008
Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature reviewRodabe N Amaria, John R Corboy, Christina A Finlayson, et al.
Journal of the Neurological Sciences|February 23, 2010
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literatureAaron Haug, Ravi Mahalingam, Randall J Cohrs, et al.
Journal of Neuropathology and Experimental Neurology|March 17, 2009
Adult cases of leukoencephalopathy, cerebral calcifications, and cysts: expanding the spectrum of the disorderBette Kay Kleinschmidt-Demasters, Thomas J Cummings, Christine M Hulette, et al.
The American Journal of Managed Care|June 4, 2013
Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosisJonathan D Campbell, R Brett McQueen, Agusto Miravalle, et al.
Journal of the Neurological Sciences|May 27, 2018
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosisBrandi Vollmer, Justin M Honce, Stefan Sillau, et al.
Human Pathology|March 26, 2005
Lymphomatosis cerebri as a cause of white matter dementiaKaren E Rollins, B K Kleinschmidt-DeMasters, John R Corboy, et al.
Journal of Neuroimmunology|April 3, 2014
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cellsDan M Waid, Teri Schreiner, Gisela Vaitaitis, et al.
Neurology|February 19, 2016
Multiple sclerosis prevalence in the United States commercially insured populationPiyameth Dilokthornsakul, Robert J Valuck, Kavita V Nair, et al.
Seminars in Neurology|January 23, 2023
Challenging Cases in NeuroimmunologyAnna A Shah, Andrew B Wolf, Anthony Declusin, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Pediatric Neurology|November 1, 2006
Neuromyelitis optica immunoglobulin G in a childLynsee A Hudson, Timothy J Bernard, Brian S Tseng, et al.
Clinical Breast Cancer|October 28, 2008
Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature reviewRodabe N Amaria, John R Corboy, Christina A Finlayson, et al.
Journal of the Neurological Sciences|February 23, 2010
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literatureAaron Haug, Ravi Mahalingam, Randall J Cohrs, et al.
Journal of Neuropathology and Experimental Neurology|March 17, 2009
Adult cases of leukoencephalopathy, cerebral calcifications, and cysts: expanding the spectrum of the disorderBette Kay Kleinschmidt-Demasters, Thomas J Cummings, Christine M Hulette, et al.
The American Journal of Managed Care|June 4, 2013
Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosisJonathan D Campbell, R Brett McQueen, Agusto Miravalle, et al.
Journal of the Neurological Sciences|May 27, 2018
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosisBrandi Vollmer, Justin M Honce, Stefan Sillau, et al.
Human Pathology|March 26, 2005
Lymphomatosis cerebri as a cause of white matter dementiaKaren E Rollins, B K Kleinschmidt-DeMasters, John R Corboy, et al.
Journal of Neuroimmunology|April 3, 2014
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cellsDan M Waid, Teri Schreiner, Gisela Vaitaitis, et al.
Neurology|February 19, 2016
Multiple sclerosis prevalence in the United States commercially insured populationPiyameth Dilokthornsakul, Robert J Valuck, Kavita V Nair, et al.
Seminars in Neurology|January 23, 2023
Challenging Cases in NeuroimmunologyAnna A Shah, Andrew B Wolf, Anthony Declusin, et al.
Pageof 9